4.7 Review

RNA-based pharmacotherapy for tumors: From bench to clinic and back

期刊

BIOMEDICINE & PHARMACOTHERAPY
卷 125, 期 -, 页码 -

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.biopha.2020.109997

关键词

RNA therapy; RNA drugs; Cancer immunotherapy; Clinical trials

资金

  1. National Natural Science Foundation of China [81541153, J18111211]
  2. Southern Science and Engineering Guangdong Laboratory Zhanjiang [ZJW-2019-07]
  3. Guangdong Provincial Science and Technology Department [2016A050503046, 2015A050502048, 2016B030309002]
  4. Public Service Platform of South China for RAMP
  5. D Marine Biomedicine Resources [GDMUK201808]
  6. Zhanjiang Science and Technology Plan [2017A06012]
  7. Group-type Special Supporting Project for Educational Talents in Universities [4SG19057G]

向作者/读者索取更多资源

RNA therapy is a treatment that regulates cell proteins and cures diseases by affecting the metabolism of mRNAs in cells, which has cut a figure in the studies on various incurable illnesses like hereditary diseases, tumors, etc. In this review, we introduced the discovery and development of RNA therapy and discussed its classification, mechanisms, advantages, and challenges. Moreover, we highlighted how RNA therapy works in killing tumor cells as well as what progresses it has made in related researches. And the development of RNA anti-tumor drugs and the clinical trial process were also included.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据